Validation of Prognostic Models for Renal Cell Carcinoma Recurrence, Cancer Specific Mortality and All-Cause Mortality.

Post-operative prognostic tools allow for improved prediction of future recurrence risk, patient counselling, assessment of eligibility for adjuvant treatments, and ensure appropriate follow-up surveillance. The purpose of this analysis is to validate existing prognostic models for patients with kidney cancer.